Donchida Srimuan

721 total citations
27 papers, 362 citations indexed

About

Donchida Srimuan is a scholar working on Infectious Diseases, Animal Science and Zoology and Epidemiology. According to data from OpenAlex, Donchida Srimuan has authored 27 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 8 papers in Animal Science and Zoology and 8 papers in Epidemiology. Recurrent topics in Donchida Srimuan's work include SARS-CoV-2 and COVID-19 Research (21 papers), COVID-19 Clinical Research Studies (12 papers) and Animal Virus Infections Studies (8 papers). Donchida Srimuan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (21 papers), COVID-19 Clinical Research Studies (12 papers) and Animal Virus Infections Studies (8 papers). Donchida Srimuan collaborates with scholars based in Thailand, United Kingdom and Belgium. Donchida Srimuan's co-authors include Nasamon Wanlapakorn, Yong Poovorawan, Thanunrat Thongmee, Preeyaporn Vichaiwattana, Chompoonut Auphimai, Nungruthai Suntronwong, Suvichada Assawakosri, Sitthichai Kanokudom, Thaksaporn Thatsanatorn and Ritthideach Yorsaeng and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Donchida Srimuan

27 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donchida Srimuan Thailand	11	296	108	71	57	50	27	362
Pornjarim Nilyanimit Thailand	12	221 0.7×	63 0.6×	117 1.6×	47 0.8×	36 0.7×	45	400
Anat Wieder-Finesod Israel	7	320 1.1×	85 0.8×	26 0.4×	60 1.1×	38 0.8×	12	355
Chompoonut Auphimai Thailand	14	312 1.1×	102 0.9×	131 1.8×	64 1.1×	50 1.0×	26	438
Suvichada Assawakosri Thailand	9	286 1.0×	91 0.8×	23 0.3×	59 1.0×	45 0.9×	22	299
Lenesha Warrener United Kingdom	11	152 0.5×	119 1.1×	197 2.8×	26 0.5×	69 1.4×	17	324
Saman Saadat United States	5	262 0.9×	58 0.5×	16 0.2×	35 0.6×	24 0.5×	12	296
Savannah K. McBride United States	8	358 1.2×	62 0.6×	19 0.3×	39 0.7×	58 1.2×	9	383
Gina S. Lee United States	9	491 1.7×	190 1.8×	51 0.7×	64 1.1×	43 0.9×	14	547
John C. Prostko United States	8	481 1.6×	65 0.6×	34 0.5×	67 1.2×	61 1.2×	20	540
Audrey L. Butler United States	6	165 0.6×	52 0.5×	60 0.8×	19 0.3×	116 2.3×	7	343

Countries citing papers authored by Donchida Srimuan

Since Specialization

Citations

This map shows the geographic impact of Donchida Srimuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donchida Srimuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donchida Srimuan more than expected).

Fields of papers citing papers by Donchida Srimuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donchida Srimuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donchida Srimuan. The network helps show where Donchida Srimuan may publish in the future.

Co-authorship network of co-authors of Donchida Srimuan

This figure shows the co-authorship network connecting the top 25 collaborators of Donchida Srimuan. A scholar is included among the top collaborators of Donchida Srimuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donchida Srimuan. Donchida Srimuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suntronwong, Nungruthai, Sitthichai Kanokudom, Chompoonut Auphimai, et al.. (2024). Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection. Vaccines. 12(2). 180–180. 3 indexed citations

Wanlapakorn, Nasamon, et al.. (2024). Persistence of Antibodies against Measles, Mumps, and Rubella after the Two-Dose MMR Vaccination: A 7-Year Follow-Up Study. Vaccines. 12(7). 744–744. 1 indexed citations

Wanlapakorn, Nasamon, et al.. (2023). Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6 months of age. Vaccine. 41(26). 3855–3861. 4 indexed citations

Suntronwong, Nungruthai, Preeyaporn Vichaiwattana, Sirapa Klinfueng, et al.. (2023). SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study. PLoS ONE. 18(4). e0279147–e0279147. 6 indexed citations

Yorsaeng, Ritthideach, Nungruthai Suntronwong, Sitthichai Kanokudom, et al.. (2023). SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis. Vaccines. 11(7). 1184–1184. 8 indexed citations

Wanlapakorn, Nasamon, Ilada Thongpan, Preeyaporn Vichaiwattana, et al.. (2023). Epidemiology and clinical characteristics of severe acute respiratory infections among hospitalized children under 5 years of age in a tertiary care center in Bangkok, Thailand, 2019–2020. Heliyon. 9(11). e22300–e22300. 7 indexed citations

Suntronwong, Nungruthai, Sitthichai Kanokudom, Suvichada Assawakosri, et al.. (2023). Neutralizing antibodies against Omicron BA.5 among children with infection alone, vaccination alone, and hybrid immunity. International Journal of Infectious Diseases. 134. 18–22. 4 indexed citations

Kanokudom, Sitthichai, Jira Chansaenroj, Nungruthai Suntronwong, et al.. (2023). The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5. Vaccines. 11(3). 570–570. 7 indexed citations

Assawakosri, Suvichada, Sitthichai Kanokudom, Nungruthai Suntronwong, et al.. (2023). Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3–4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination. Heliyon. 10(1). e23892–e23892. 5 indexed citations

10.

Chansaenroj, Jira, Preeyaporn Vichaiwattana, Donchida Srimuan, et al.. (2023). Dynamics of Cytokine, SARS-CoV-2-Specific IgG, and Neutralizing Antibody Levels in COVID-19 Patients Treated with Convalescent Plasma. SHILAP Revista de lepidopterología. 11(3). 112–112. 3 indexed citations

11.

Wanlapakorn, Nasamon, Nungruthai Suntronwong, Ritthideach Yorsaeng, et al.. (2022). Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study. Human Vaccines & Immunotherapeutics. 18(1). 2029111–2029111. 47 indexed citations

12.

Assawakosri, Suvichada, Sitthichai Kanokudom, Nungruthai Suntronwong, et al.. (2022). Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination. The Journal of Infectious Diseases. 226(8). 1372–1381. 41 indexed citations

13.

Assawakosri, Suvichada, Sitthichai Kanokudom, Jira Chansaenroj, et al.. (2022). Persistence of immunity against Omicron BA.1 and BA.2 variants following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-dose AZD1222 vaccination. International Journal of Infectious Diseases. 122. 793–801. 13 indexed citations

14.

Kanokudom, Sitthichai, Suvichada Assawakosri, Nungruthai Suntronwong, et al.. (2022). Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine. Vaccines. 10(1). 86–86. 48 indexed citations

15.

Suntronwong, Nungruthai, Suvichada Assawakosri, Sitthichai Kanokudom, et al.. (2022). Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination. Diagnostics. 12(8). 1781–1781. 13 indexed citations

16.

Chansaenroj, Jira, Nungruthai Suntronwong, Sitthichai Kanokudom, et al.. (2022). Immunogenicity Following Two Doses of the BBIBP-CorV Vaccine and a Third Booster Dose with a Viral Vector and mRNA COVID-19 Vaccines against Delta and Omicron Variants in Prime Immunized Adults with Two Doses of the BBIBP-CorV Vaccine. Vaccines. 10(7). 1071–1071. 11 indexed citations

17.

Suntronwong, Nungruthai, Ritthideach Yorsaeng, Jiratchaya Puenpa, et al.. (2022). COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron. Vaccines. 10(3). 391–391. 13 indexed citations

18.

Kanokudom, Sitthichai, Suvichada Assawakosri, Nungruthai Suntronwong, et al.. (2022). Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine. Vaccine. 40(39). 5657–5663. 7 indexed citations

19.

Puenpa, Jiratchaya, Jira Chansaenroj, Chompoonut Auphimai, et al.. (2020). Neutralizing antibody against Enterovirus-A71 in Thai children: A longitudinal study from birth to age 4 years. Vaccine. 38(48). 7638–7644. 2 indexed citations

20.

Wanlapakorn, Nasamon, Kirsten Maertens, Surasith Chaithongwongwatthana, et al.. (2018). Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women. Vaccine. 36(11). 1453–1459. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact